Nobivac Parvo-C Lyophilisate for Suspension for Injection for Dogs
Active ingredient: Canine parvovirus
Form
Injection
Species
Manufacturer
Intervet International B.V.
VMD MA No.
06376/4105
What it's used for
Onset of immunity: 1 week. Duration of immunity: 3 years.
Full indications, dosage and side effects ↓The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Canine parvovirus
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Nobivac Parvo-C Lyophilisate for Suspension for Injection for Dogs — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.
Duration of immunity: 3 years.
vaccines listed in section 3.8.
Avoid contamination of vaccine with traces of chemical sterilising agents. Do not use
chemicals such as disinfectant or spirit to disinfect the skin prior to administration.
Maternal antibodies can negatively interfere with the efficacy of a vaccine. Strict
adherence to the vaccination programme is therefore recommended.
Vaccination programme:
Primary vaccination:
A single injection should establish active immunity to disease caused by canine
parvovirus infection in dogs of 10 weeks of age or older. Where earlier protection is
required a first dose may be given to puppies from 4 weeks of age, but because
maternally derived passive antibodies can interfere with the response to vaccination,
a final dose at 10 weeks of age or older is generally recommended.
Revaccination:
It is recommended that dogs be revaccinated against canine parvovirus every
3 years.
Common
(1 to 10 animals / 100 animals
treated):
Injection site swelling
1,2
Very rare
(<1 animal / 10,000 animals
treated, including isolated reports):
Hypersensitivity reaction (e.g. lethargy, facial
oedema, pruritus, vomiting or diarrhoea)
2,3
Diffuse, up to 5 mm in diameter, which can occasionally be hard and painful and
can last for up to 3 days post injection.
Transient, shortly after vaccination.
Such reaction may evolve to a more severe condition (anaphylaxis), which may be
life-threatening with additional signs like dyspnoea and collapse. If such reaction
occurs, appropriate treatment is recommended.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
The vaccine may not be effective in dogs incubating the disease at the time of
vaccination.
A good immune response is reliant on the reaction of an immunogenic agent and a
fully competent immune system. Immunocompetence of the animal may be
compromised by a variety of factors including poor health, nutritional status, genetic
factors, concurrent drug therapy and stress.
The immunogenicity of the vaccine antigen will be reduced by poor storage or
inappropriate administration.
The vaccine has been proved to be of benefit against virulent challenge in the
presence of maternal antibody levels to CPV that are likely to be encountered under
field conditions.
Experience has shown that the maternal antibody status of pups within a litter varies
greatly, and reliance should not be placed on serological examination of the bitch
alone.
Special precautions for safe use in the target species:
Animals that have received a corresponding anti-serum or immunosuppressive drugs
should not be vaccinated until an interval of at least 4 weeks has elapsed.
Vaccinated dogs may excrete the parvovirus vaccine strain at very low levels for up
to 8 days after vaccination. However, there is no evidence of any reversion to
virulence of the vaccine strain and therefore no need to separate unvaccinated dogs
from contact with recently vaccinated dogs.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
mixed and administered with the inactivated vaccines in the Nobivac range against
canine leptospirosis caused by all or some of the following serovars:
serogroup Canicola serovar Canicola, L. interrogans serogroup Icterohaemorrhagiae
serovar Copenhageni, L. interrogans serogroup Australis serovar Bratislava, and
L. kirschneri
After administration with one of the leptospirosis vaccines, a mild and transient
increase in body temperature 1 °C) may occur for a few days after vaccination,
with some pups showing less activity and/or a reduced appetite. A small transient
swelling ( 4 cm), which can occasionally be firm and painful on palpation, may be
observed at the site of injection. Any such swelling will either have disappeared or be
clearly diminished by 14 days post vaccination.
After mixed administration of an overdose of this vaccine and an overdose of the
leptospirosis vaccines in the Nobivac range, transient local reactions such as diffuse
to firm swellings from 1 to 5 cm in diameter may be observed, usually these will
persist no longer than 5 weeks, however some may take a little longer to completely
disappear.
Safety and efficacy data are available which demonstrate that this vaccine can be
mixed and administered with the inactivated vaccine in the Nobivac range against
rabies. After administration with the rabies vaccine, where this product is authorised,
transient local reactions such as diffuse to firm swellings from 1 to 4 cm in diameter
may be observed for up to 3 weeks after vaccination. The swellings may be painful
for up to 3 days post-vaccination.
Safety and efficacy data are available which demonstrate that this vaccine can be
administered at the same time but not mixed with the inactivated vaccine of the
Nobivac range against Bordetella bronchiseptica
Product information of the relevant Nobivac vaccines should be consulted before
mixed product administration.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the products mentioned above.
A decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.
Do not freeze.
Protect from light.
Avoid prolonged or repetitive exposure to high ambient temperatures following
withdrawal from the refrigerator prior to use. In hot summer conditions vaccine
potency can be severely reduced within a few hours.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Related Conditions
Other Products Containing Canine parvovirus
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Canigen DHP Lyophilisate and Solvent for Suspension for Injection for Dogs
POM-VIntervet International B.V.
Canigen DHPPi Lyophilisate for Suspension for Injection for Dogs
POM-VIntervet International B.V.
Canigen Parvo-C Lyophilisate for Suspension for Injection for Dogs
POM-VIntervet International B.V.
Canixin DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs
POM-VVirbac
Canixin DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs
POM-VVirbac
Canixin DHPPi/L
POM-VVIRBAC
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
VetBox Flea & Worm Protection for Dogs
Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Aftopur AlSap
POM-VFoot-and-mouth disease virus
Aftopur AlSap
POM-VFoot-and-mouth disease virus
Aftopur DOE
POM-VFoot-and-mouth disease virus
Aftopur DOE
POM-VFoot-and-mouth disease virus
Alpha Ject Micro 1 PD Emulsion for Injection for Atlantic Salmon
POM-VSalmon pancreas disease virus
Alpha Ject Micro 1 PD Emulsion for Injection for Atlantic Salmon
POM-VSalmon pancreas disease virus
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.